What types of data can I screen with a Aarey Drugs screener?

The Aarey Drugs screener can be used to check different types of data, such as market capitalization, stock P/E, PB ratio, current price, book value, ROE, 52W high/low, dividend yield, and face value. It also shows short-term and long-term data of the Aarey Drugs.

What is the importance of using a stock screener for analyzing Aarey Drugs?

You can use the Aarey Drugs stock screener to analyze stocks based on specific criteria, helping you choose stocks for investments based on real-time data.

Is the Aarey Drugs Stock Screener suitable for both short-term and long-term investors?

Yes, you can use the Aarey Drugs Stock Screener for both short-term and long-term. Using the short term, you can check data for periods ranging from 1 week to 6 months. On the other hand, if you are looking to invest long-term, you can check data for periods ranging from 1 year to 10 years.

Home

Stock Screener

Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd Screener

Market Cap

₹ 196.44 Cr.

Stocks P/E

PB Ratio

0 %

Current Price

₹ 69.28

Book Value

₹ 0

ROE

0 %

High/Low

₹ 100/32.85

Dividend Yield

0 %

Face Value

₹ 1

Small Cap

With a marketcap of ₹ 196.44 Cr Stock is ranked 2554

Market Cap

₹ 196.44 Cr.

Stocks P/E

PB Ratio

0 %

Current Price

₹ 69.28

Book Value

₹ 0

ROE

0 %

High/Low

₹ 100/32.85

Dividend Yield

0 %

Face Value

₹ 1

Small Cap

With a marketcap of ₹ 196.44 Cr Stock is ranked 2554

Aarey Drugs Investment Return

Short Term

1 Week

5.95 %

1 Month

-12.58 %

3 Months

-4.12 %

6 Months

-12.77 %

Long Term

1 Year

88.38 %

3 Years

173.56 %

5 Years

180.12 %

10 Years

128.56 %

Aarey Drugs Return Calculator

Investment

₹

Investment Period

Expected Return

Invested Amount

₹ 0

Wealth Gained

Expected Return

₹ 0

Invested Amount

Wealth Gained

₹ 0

Expected Return

Aarey Drugs Revenue and Profit and Growth

Aarey Drugs Screener FAQs

Unlimited Trading starting at just ₹249 ₹0

Open Trading Account

+91

*By signing up you agree to our terms & conditions